1st Quarter - Report

BIOMET, INC. for BIOMET, INC.

Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 436 - Protect Medical Innovation Act; FDA 510(k) Reform Proposal; S.17-Medical Device Access and Innovation Act; S. 727, Bill to Amend Internal Revenue Code of 1986; Physician-owned distributorships; CMS reimbursement; Veterans' Affairs

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 727 (112th), S. 17 (112th), H.R. 436 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.